Amicus Therapeutics, Inc. - FOLD

SEC FilingsOur FOLD Tweets

About Gravity Analytica

Recent News

  • 02.03.2026 - Amicus Therapeutics Presents New Long-term Data for both Galafold® (migalastat) and POMBILITI® (cipaglucosidase alfa-atga) + OPFOLDA® (miglustat) at the 22nd Annual WORLDSymposium™ 2026

Recent Filings

  • 02.02.2026 - DEFM14A Definitive proxy statement relating to merger or acquisition
  • 01.26.2026 - 8-K Current report
  • 01.26.2026 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
  • 01.22.2026 - 4 Statement of changes in beneficial ownership of securities
  • 01.21.2026 - PREM14A Preliminary proxy statements relating to merger or acquisition
  • 01.20.2026 - 144 Report of proposed sale of securities
  • 01.06.2026 - 4 Statement of changes in beneficial ownership of securities
  • 01.06.2026 - 4 Statement of changes in beneficial ownership of securities
  • 01.06.2026 - 4 Statement of changes in beneficial ownership of securities
  • 01.06.2026 - 4 Statement of changes in beneficial ownership of securities